908 Devices To Acquire NIRLAB AG, A Maker Of AI-Powered, Cloud-Connected Near-Infrared Spectroscopy To Perform Handheld Chemical Analysis Of Narcotics, Terms Not Disclosed

908 Devices Inc.

908 Devices Inc.

MASS

0.00

This acquisition expands 908 Devices' analytical portfolio and strengthens its leadership in narcotics detection with NIRLAB's solution for fast, high-volume screening for everyday law enforcement patrol.

The NIRLAB handheld device enables safe, point-and-click analysis of more than 400 common drugs, such as cocaine and methamphetamine, directly or through thin plastic bags and glass, delivering results in seconds, to support real-time decision-making in the field. Beyond identification, it quantifies drug purity in complex mixtures and can analyze cannabis, including percentages of THC and CBD. Proven in the field with over one million analyses, the platform integrates an intuitive mobile app, seamless device connectivity, and a subscription model that delivers continuous updates and evolving capabilities.